WebDec 6, 2024 · Trince has raised EUR 4 million from Novalis Biotech Acceleration, Qbic II, and private investors. Within five years, the company wants to grow to 35 to 40 employees and use its technology to improve the quality of cell therapies and make them more affordable. Today, five cell therapies have already been approved to fight blood cancer. WebAbout Novalis Biotech Acceleration Novalis Biotech (Ghent, Belgium) is an early-stage venture capital investor in technologies that revolutionize healthcare. The company’s core competence lies in digitalization in the life sciences with a focus on “enabling technologies” such as bioinformatics, genomics and diagnostics. ...

生命科学 第2页 前途科技

WebNov 23, 2024 · For the Novalis Acceleration Fund, investments will be split between approximately 10 early stage incubation projects and about 10 acceleration projects, … WebSep 9, 2024 · Novalis Biotech Acceleration Fund I is an early-stage venture capital fund managed by Novalis Biotech. The fund is located in Gent, Belgium, and invests in Benelux region. The fund targets to invest in the healthcare sector. cloudfield projector

Novalis Biotech Acceleration invests in Modality.AI

WebCategory. Novalis Biotech, an early stage venture capital investor in technologies to revolutionize healthcare, announced the successful first closing of its second fund, Novalis Biotech Acceleration, raising an initial €8 million. With commitments for a similar amount already in place, Novalis anticipates a final closing in early 2024. Web[LEVEE DE FONDS] Carroucell lève un total de 1,5 million d'euros pour accélérer la croissance de l'entreprise par l'industrialisation de la plateforme… WebThe funding includes a Series A financing led by the Novalis Biotech Acceleration fund, ... Novalis Biotech is an early stage venture capital fund in life sciences, focusing on enabling ... cloud fichiers gratuit